Overview
Mary Okimoto is a Nurse Practitioner in San Luis Obispo, California. Ms. Okimoto is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Ampullary Cancer, Marginal Zone Lymphoma (MZL), and ALK-Positive Non-Small Cell Lung Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
892 Aerovista Pl, Suite 240, San Luis Obispo, CA 93401
2020 Santa Monica Blvd, Suite 210, Santa Monica, CA 90404
Pacific Central Coast Health Centers
Tracy Tilley is a Nurse Practitioner in Santa Maria, California. Ms. Tilley is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Pancreatic Ductal Adenocarcinoma, Smoldering Multiple Myeloma, Febrile Neutropenia, and Small Lymphocytic Lymphoma (SLL).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerMs. Okimoto isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Ampullary CancerMs. Okimoto isExperienced. Learn about Ampullary Cancer.
- Marginal Zone Lymphoma (MZL)Ms. Okimoto isExperienced. Learn about Marginal Zone Lymphoma (MZL).